Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Bio-Rad Labs Inc. A buy UBS Group AG

Bio-Rad Labs Inc. A
Start price
€248.20
08.05.24 / 50%
Target price
€357.93
08.05.25
Performance (%)
9.59%
Price
€272.00
16.05.24
Summary
This prediction is currently active. With a performance of 9.59%, the BUY prediction by UBS_Group_AG for Bio-Rad Labs Inc. A is trending in the right direction. This prediction currently runs until 08.05.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w
Bio-Rad Labs Inc. A 3.856%
iShares Core DAX® -0.383%
iShares Nasdaq 100 1.248%
iShares Nikkei 225® 0.525%
iShares S&P 500 0.640%

Comments by UBS_Group_AG for this prediction

In the thread Bio-Rad Labs Inc. A diskutieren
Prediction Buy
Perf. (%) 9.59%
Target price 357.935
Change
Ends at 08.05.25

Bio-Rad Laboratories, Inc. (NYSE: BIO) had its price target lowered by analysts at UBS Group AG from $420.00 to $385.00. They now have a "buy" rating on the stock.
Ratings data for BIO provided by MarketBeat

UBS Group AG 
0
Report Share
08.05.24

Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A

buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€316.20
16.02.24
€389.51
16.02.25
-13.98%
16.05.24

UBS Group AG 
16.02.24 50%
buy
Bio-Rad Labs Inc. A

Start price
Target price
Perf. (%)
€285.60
07.12.23
€365.97
07.12.24
-4.76%
16.05.24

UBS Group AG 
07.12.23 50%